Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Combination of adriamycin and cyclophosphamide in the treatment of metastatic prostatic carcinoma: a phase II study.

Izbicki RM, Amer MH, Al-Sarraf M.

Cancer Treat Rep. 1979 Jun;63(6):999-1001.

PMID:
380805
3.
5.

Chemotherapy of advanced prostatic cancer with adriamycin, BCNU, and cyclophosphamide.

Presant CA, Van Amburg A 3rd, Klahr C, Metter GE.

Cancer. 1980 Dec 1;46(11):2389-92.

6.

Adriamycin and cyclophosphamide versus hydroxyurea in advanced prostatic cancer. A randomized Southwest Oncology Group study.

Stephens RL, Vaughn C, Lane M, Costanzi J, O'Bryan R, Balcerzak SP, Levin H, Frank J, Coltman CA Jr.

Cancer. 1984 Feb 1;53(3):406-10.

7.

Chemotherapy for stage III-IV epithelial ovarian cancer with cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide: a preliminary report.

Ehrlich CE, Einhorn L, Williams SD, Morgan J.

Cancer Treat Rep. 1979 Feb;63(2):281-8. No abstract available.

PMID:
376134
8.

Oral estramustine and cyclophosphamide in patients with metastatic hormone refractory prostate carcinoma: a phase II study.

Bracarda S, Tonato M, Rosi P, De Angelis V, Mearini E, Cesaroni S, Fornetti P, Porena M.

Cancer. 2000 Mar 15;88(6):1438-44.

PMID:
10717628
9.

Combination chemotherapy for metastatic breast cancer: comparison of multiple drug therapy with 5-fluorouracil, cytoxan and prednisone with adriamycin or adrenalectomy.

Nemoto T, Rosner D, Diaz R, Dao T, Sponzo R, Cunningham T, Horton J, Simon R.

Cancer. 1978 Jun;41(6):2073-7. No abstract available.

12.

Mitoxantrone, cyclophosphamide, and 5-fluorouracil in the treatment of hormonally unresponsive metastatic breast cancer.

Holmes FA, Yap HY, Esparza L, Buzdar AU, Hortobagyi GN, Blumenschein GR.

Semin Oncol. 1984 Sep;11(3 Suppl 1):28-31.

PMID:
6385262
13.

A randomized study of doxorubicin versus doxorubicin plus cisplatin in endocrine-unresponsive metastatic prostatic carcinoma.

Torti FM, Shortliffe LD, Carter SK, Hannigan JF Jr, Aston D, Lum BL, Williams RD, Spaulding JT, Freiha FS.

Cancer. 1985 Dec 1;56(11):2580-6.

14.

Combination chemotherapy for advanced breast cancer: two regimens containing adriamycin.

Kennealey GT, Boston B, Mitchell MS, Knobf MK, Bobrow SN, Pezzimenti JF, Lawrence R, Bertino JR.

Cancer. 1978 Jul;42(1):27-33.

15.
16.
17.

Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.

Dhingra K, Frye D, Newman RA, Walters R, Theriault R, Fraschini G, Smith T, Buzdar A, Hortobagyi GN.

Clin Cancer Res. 1995 Jul;1(7):691-7.

18.

Randomized trial of combination chemotherapy in hormone-resistant metastatic prostate carcinoma.

Page JP, Levi JA, Woods RL, Tattersall MN, Fox RM, Coates AS.

Cancer Treat Rep. 1985 Jan;69(1):105-7.

PMID:
3881176
20.

[Cyclophosphamide, adriamycin and cisplatinum combination chemotherapy for advanced urothelial and prostatic carcinoma].

Tsukamoto T, Tanoguchi H, Nakazono M, Murai M, Tachibana M, Deguchi N, Baba S, Hata M, Jitsukawa S, Tazaki H.

Gan To Kagaku Ryoho. 1987 Dec;14(12):3259-64. Japanese.

PMID:
3688891

Supplemental Content

Support Center